A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Clinical trial NCT04642365 · TERMINATED
Trial details
- NCT number
- NCT04642365
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2024-01-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.